Woodline Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-138,871
| Closed | -$31.1M | – | 1064 |
|
|
2025
Q1 | $31.1M | Buy |
138,871
+119,417
| +614% | +$26.7M | 0.2% | 154 |
|
|
2024
Q4 | $6.37M | Buy |
+19,454
| New | +$6.37M | 0.04% | 437 |
|
|
2024
Q2 | – | Sell |
-166,588
| Closed | -$65.9M | – | 686 |
|
|
2024
Q1 | $65.9M | Buy |
166,588
+147,018
| +751% | +$58.2M | 0.61% | 39 |
|
|
2023
Q4 | $6.89M | Buy |
+19,570
| New | +$6.89M | 0.07% | 271 |
|
|
2023
Q2 | – | Sell |
-81,725
| Closed | -$28.3M | – | 761 |
|
|
2023
Q1 | $28.3M | Buy |
81,725
+32,453
| +66% | +$11.2M | 0.39% | 77 |
|
|
2022
Q4 | $11.6M | Buy |
+49,272
| New | +$11.6M | 0.16% | 185 |
|
|
2021
Q1 | – | Sell |
-33,980
| Closed | -$9.63M | – | 480 |
|
|
2020
Q4 | $9.63M | Buy |
+33,980
| New | +$9.63M | 0.26% | 118 |
|